CLINICAL_TRIALS
trial_result
· 2013-05-22
Clinical Trial Update: A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma [Phase 2]
Summary
Phase II study evaluating oral cyclophosphamide with sirolimus (OCR) in advanced osteosarcoma. The trial's results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan Rogel Cancer Center | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2013-05-22